WHO 2008 mature T-cell and NK-cell neoplasms
| Mature T-cell and NK-cell neoplasms . | Incidence (%)* . |
|---|---|
| T-cell prolymphocytic leukemia | |
| T-cell large granular lymphocytic leukemia | |
| Chronic lymphoproliferative disorder of NK cells† | |
| Aggressive NK-cell leukemia | |
| Systemic EBV-positive T-cell lymphoproliferative disease of childhood | |
| Hydroa vacciniforme-like lymphoma | |
| Adult T-cell leukemia/lymphoma | 9.6 |
| Extranodal NK/T-cell lymphoma, nasal type | 10.4 |
| Enteropathy-associated T-cell lymphoma | 4.7 |
| Hepatosplenic T-cell lymphoma | |
| Subcutaneous panniculitis-like T-cell lymphoma | 0.9 |
| Mycosis fungoides | |
| Sézary syndrome | |
| Primary cutaneous CD30+ T-cell lymphoproliferative disorders | |
| Lymphomatoid papulosis | |
| Primary cutaneous anaplastic large cell lymphoma | 1.7 |
| Primary cutaneous γδ T-cell lymphoma | |
| Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma† | |
| Primary cutaneous CD4+ small/medium T-cell lymphoma† | |
| Peripheral T-cell lymphoma, NOS | 25.6 |
| Angioimmunoblastic T-cell lymphoma | 19.5 |
| Anaplastic large cell lymphoma, ALK-positive | 6.6 |
| Anaplastic large cell lymphoma, ALK-negative† | 5.5 |
| Mature T-cell and NK-cell neoplasms . | Incidence (%)* . |
|---|---|
| T-cell prolymphocytic leukemia | |
| T-cell large granular lymphocytic leukemia | |
| Chronic lymphoproliferative disorder of NK cells† | |
| Aggressive NK-cell leukemia | |
| Systemic EBV-positive T-cell lymphoproliferative disease of childhood | |
| Hydroa vacciniforme-like lymphoma | |
| Adult T-cell leukemia/lymphoma | 9.6 |
| Extranodal NK/T-cell lymphoma, nasal type | 10.4 |
| Enteropathy-associated T-cell lymphoma | 4.7 |
| Hepatosplenic T-cell lymphoma | |
| Subcutaneous panniculitis-like T-cell lymphoma | 0.9 |
| Mycosis fungoides | |
| Sézary syndrome | |
| Primary cutaneous CD30+ T-cell lymphoproliferative disorders | |
| Lymphomatoid papulosis | |
| Primary cutaneous anaplastic large cell lymphoma | 1.7 |
| Primary cutaneous γδ T-cell lymphoma | |
| Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma† | |
| Primary cutaneous CD4+ small/medium T-cell lymphoma† | |
| Peripheral T-cell lymphoma, NOS | 25.6 |
| Angioimmunoblastic T-cell lymphoma | 19.5 |
| Anaplastic large cell lymphoma, ALK-positive | 6.6 |
| Anaplastic large cell lymphoma, ALK-negative† | 5.5 |